These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 26214772

  • 1. Efficacy of standard dose rituximab for refractory idiopathic thrombocytopenic purpura in children.
    Dai WJ, Zhang RR, Yang XC, Yuan YF.
    Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2379-83. PubMed ID: 26214772
    [Abstract] [Full Text] [Related]

  • 2. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura].
    Wang W, Yu QH, Zhang HY, Chu XX, Chen F, Zhang CQ, Zhou YH, Hou M.
    Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):225-7. PubMed ID: 18785508
    [Abstract] [Full Text] [Related]

  • 3. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y, Karapinar TH, Oymak Y, Toret E, Demirag B, Ince D, Ozcan E, Moueminoglou N, Koker SA, Vergin C.
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [Abstract] [Full Text] [Related]

  • 4. [Clinical efficacy of lower dose rituximab for chronic refractory immune thrombocytopenic purpura].
    Li Y, Wang XM, Mao M, Zhang XY, Fu L, Ai HM, Zhang LX.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):204-6. PubMed ID: 22781608
    [Abstract] [Full Text] [Related]

  • 5. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [Abstract] [Full Text] [Related]

  • 6. A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).
    Tran H, Brighton T, Grigg A, McRae S, Dixon J, Thurley D, Gandhi MK, Truman M, Marlton P, Catalano J.
    Br J Haematol; 2014 Oct; 167(2):243-51. PubMed ID: 25041261
    [Abstract] [Full Text] [Related]

  • 7. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L, Alexandrescu D, Dutcher JP, O'Boyle KP, Eapen S, Wiernik PH.
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [Abstract] [Full Text] [Related]

  • 8. Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment.
    Parodi E, Nobili B, Perrotta S, Rosaria Matarese SM, Russo G, Licciardello M, Zecca M, Locatelli F, Cesaro S, Bisogno G, Giordano P, De Mattia D, Ramenghia U.
    Int J Hematol; 2006 Jul; 84(1):48-53. PubMed ID: 16867902
    [Abstract] [Full Text] [Related]

  • 9. Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial.
    Ghanima W, Khelif A, Waage A, Michel M, Tjønnfjord GE, Romdhan NB, Kahrs J, Darne B, Holme PA, RITP study group.
    Lancet; 2015 Apr 25; 385(9978):1653-61. PubMed ID: 25662413
    [Abstract] [Full Text] [Related]

  • 10. Treatment of chronic immune thrombocytopenic purpura with rituximab in children.
    Dogan M, Oner AF, Acikgoz M, Uner A.
    Indian J Pediatr; 2009 Nov 25; 76(11):1141-4. PubMed ID: 20092026
    [Abstract] [Full Text] [Related]

  • 11. B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
    Zaja F, Vianelli N, Sperotto A, De Vita S, Iacona I, Zaccaria A, Masolini P, Tomadini V, Tani M, Molinari AL, Baccarani M, Fanin R.
    Haematologica; 2003 May 25; 88(5):538-46. PubMed ID: 12745273
    [Abstract] [Full Text] [Related]

  • 12. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C, Reu FJ, Ho AD, Hensel M.
    Ann Hematol; 2007 Oct 25; 86(10):711-7. PubMed ID: 17622529
    [Abstract] [Full Text] [Related]

  • 13. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
    Garcia-Chavez J, Majluf-Cruz A, Montiel-Cervantes L, Esparza MG, Vela-Ojeda J, Mexican Hematology Study Group.
    Ann Hematol; 2007 Dec 25; 86(12):871-7. PubMed ID: 17874322
    [Abstract] [Full Text] [Related]

  • 14. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
    Zhang C, Liu HF, Chen XH, Gao L, Gao L, Liu Y, Kong PY, Sun AH, Zhang X.
    Clin Ther; 2014 Mar 01; 36(3):385-8. PubMed ID: 24594069
    [Abstract] [Full Text] [Related]

  • 15. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura.
    Zaja F, Battista ML, Pirrotta MT, Palmieri S, Montagna M, Vianelli N, Marin L, Cavallin M, Bocchia M, Defina M, Ippoliti M, Ferrara F, Patriarca F, Avanzini MA, Regazzi M, Baccarani M, Isola M, Soldano F, Fanin R.
    Haematologica; 2008 Jun 01; 93(6):930-3. PubMed ID: 18403395
    [Abstract] [Full Text] [Related]

  • 16. Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura.
    Gall B, Yee A, Berry B, Bircham D, Hayashi A, Dansereau J, Hart J.
    J Obstet Gynaecol Can; 2010 Dec 01; 32(12):1167-1171. PubMed ID: 21176329
    [Abstract] [Full Text] [Related]

  • 17. Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.
    Oved JH, Lee CSY, Bussel JB.
    J Pediatr; 2017 Dec 01; 191():225-231. PubMed ID: 29173312
    [Abstract] [Full Text] [Related]

  • 18. Effects of rituximab and dexamethasone on regulatory and proinflammatory B-cell subsets in patients with primary immune thrombocytopenia.
    Gudbrandsdottir S, Brimnes M, Køllgaard T, Hasselbalch HC, Nielsen CH.
    Eur J Haematol; 2018 Jan 01; 100(1):45-52. PubMed ID: 28960473
    [Abstract] [Full Text] [Related]

  • 19. [Use of rituximab in resistant thrombocytopenic purpura].
    Zambrano-Velarde MA, de la O-Peña D, Chávez-Peña Q, Bedolla-Barajas M.
    Rev Med Inst Mex Seguro Soc; 2012 Jan 01; 50(2):203-8. PubMed ID: 22882991
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy of lower dose rituximab therapy for idiopathic thrombocytopenic purpura.].
    Sui T, Xue F, Zhao HF, Ge J, Zhou H, Zhang L, Bai J, Yang RC.
    Zhonghua Xue Ye Xue Za Zhi; 2010 Mar 01; 31(3):161-3. PubMed ID: 20510104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.